OBJECTIVE: Vaporized perfluorocarbon (PFC) is a treatment for lung injury; this study investigated its mode of action and potential protective effects on other organs, which are unclear. METHODS: Acute lung injury was induced by lung lavage with artificial seawater in 32 female New Zealand White rabbits. Animals received either conventional mechanical ventilation (CMV), positive end-expiratory pressure under CMV (PEEP), vaporized PFC ventilation, or positive end-expiratory pressure with vaporized PFC ventilation (PEEP + PFC). Histopathology of the lung, small intestine, liver and kidney were investigated. Matrix metalloproteinase (MMP)-9 mRNA levels in the lung were analysed. RESULTS: Pathological injury of the lung was significantly alleviated in the PEEP, PFC and PEEP + PFC groups compared with the CMV group. Tissue damage in the liver, kidney and small intestine was similar between all groups. MMP-9 mRNA levels in the PEEP, PFC and PEEP + PFC groups were significantly lower than those in the CMV group. CONCLUSIONS: Vaporized PFC ventilation can significantly alleviate lung injury but has no significant protective effect on other organs. Alleviation of lung injury may be associated with MMP-9 inhibition.
ZambonMVincentJL: Mortality rates for patients with acute lung injury/ARDS have decreased over time. Chest2008; 133: 1120–1127.
6.
BleylJURagallerMTschöU: Vaporized perfluorocarbon improves oxygenation and pulmonary function in an ovine model of acute respiratory distress syndrome. Anesthesiology1999; 91: 461–469.
7.
HüblerMSoudersJEShadeED: Effects of vaporized perfluorocarbon on pulmonary blood flow and ventilation/perfusion distribution in a model of acute respiratory distress syndrome. Anesthesiology2001; 95: 1414–1421.
8.
ZhaoXWZhangJPHuangX: Effects of vaporized perfluorocarbon therapy on seawater respiratory distress syndrome in rabbit models. Zhonghua Jie He He Hu Xi Za Zhi2010; 33: 169–173 [in Chinese, English abstract].
9.
NestiFDFuhrmanBPSteinhornDMPerfluorocarbon-associated gas exchange in gastric aspiration. Crit Care Med1994; 22: 1445–1452.
10.
LeachCLFuhrmanBPMorinFC3rd: Perfluorocarbon-associated gas exchange (partial liquid ventilation) in respiratory distress syndrome: A prospective, randomized, controlled study. Crit Care Med1993; 21: 1270–1278.
11.
PapoMCPaczanPRFuhrmanBP: Perfluorocarbon-associated gas exchange improves oxygenation, lung mechanics, and survival in a model of adult respiratory distress syndrome. Crit Care Med1996; 24: 466–474.
12.
BabaAKimYKZhangHPerfluorocarbon blocks tumor necrosis factor-α-induced interleukin-8 release from alveolar epithelial cells in vitro. Crit Care Med2000; 28: 1113–1118.
13.
KochTRagallerMHaufeDPerfluorohexane attenuates proinflammatory and procoagulatory response of activated monocytes and alveolar macrophages. Anesthesiology2001: 94: 101–109.
ThomassenMJBuhrowLTWiedemannHP: Perflubron decreases inflammatory cytokine production by human alveolar macrophages. Crit Care Med1997; 25: 2045–2047.
16.
von der HardtKSchoofEKandlerMAAerosolized perfluorocarbon suppresses early pulmonary inflammatory response in a surfactant-depleted piglet model. Pediatr Res2002; 51: 177–182.
17.
WarnerRLBhagavathulaNNerusuKC: Matrix metalloproteinase in acute inflammation: induction of MMP-3 and MMP-9 in fibroblasts and epithelial cells following exposure to pro-inflammatory mediators in vitro. Exp Mol Pathol2004; 76: 189–195.
18.
CederqvistKJanerJTervahartialaT: Up-regulation of trypsin and mesenchymal MMP-8 during development of hyperoxic lung injury in the rat. Pediatr Res2006; 60: 395–400.
19.
TanRJFattmanCLNiehouseLM: Matrix metalloproteinases promote inflammation and fibrosis in asbestos-induced lung injury in mice. Am J Respir Cell Mol Biol2006; 35: 289–297.
20.
SenAIForonjyRFShiomiT: Loss of MMP-13 delays inflammatory response after acute hyperoxic lung injury. Proc Am Thorac Soc2008; 5: 360–361.
21.
SchmalfeldtBPrechtelDHärtingK: Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer. Clin Cancer Res2001; 7: 2396–2404.
22.
AtkinsonJJSeniorRM: Matrix metallo-proteinase-9 in lung remodeling. Am J Respir Cell Mol Biol2003; 28: 12–24.
23.
DelclauxCd'OrthoMPDelacourtC: Gelatinases in epithelial lining fluid of patients with adult respiratory distress syndrome. Am J Physiol1997; 272: L442–L451.
24.
LemjabbarHGossetPLamblinC: Contribution of 92 kDa gelatinase/type IV collagenase in bronchial inflammation during status asthmaticus. Am J Respir Crit Care Med1999; 159: 1298–1307.
25.
LemjabbarHGossetPZalcmanE Lechapt: Overexpression of alveolar macrophage gelatinase B (MMP-9) in patients with idiopathic pulmonary fibrosis: effects of steroid and immunosuppressive treatment. Am J Respir Cell Mol Biol1999; 20: 903–913.
26.
DoroszkoAHurstTSPolewiczD: Effects of MMP-9 inhibition by doxycycline on proteome of lungs in high tidal volume mechanical ventilation-induced acute lung injury. Proteome Sci2010; 8: 3.
27.
XinminDYunyouDChaoshengP: Dexamethasone treatment attenuates early seawater instillation-induced acute lung injury in rabbits. Pharmacol Res2006; 53: 372–379.
28.
FolkessonHGKheradmandFMatthayMA: The effect of salt water on alveolar epithelial barrier function. Am J Respir Crit Care Med1994; 150: 1555–1563.
29.
DerksCMJacobovitz-DerksD: Embolic pneumopathy induced by oleic acid. A systematic morphologic study. Am J Pathol1977; 87: 143–158.
30.
SchlagGRedlHvan VuurenCJ: Hyperdynamic sepsis in baboons: II. Relation of organ damage to severity of sepsis evaluated by a newly developed morphological scoring system. Circ Shock1992; 38: 253–263.
31.
ZhangXPZhangLWangY: Study of the protective effects of dexamethasone on multiple organ injury in rats with severe acute pancreatitis. JOP2007; 8: 400–412.
32.
PfafflMW: A new mathematical model for relative quantification in real-time RT—PCR. Nucleic Acids Res2001; 29: e45.
33.
HerreraMTToledoCValladaresF: Positive end-expiratory pressure modulates local and systemic inflammatory responses in a sepsis-induced lung injury model. Intensive Care Med2003; 29: 1345–1353.
34.
NakazawaKYokoyamaKYamakawaN: Effect of positive end-expiratory pressure on inflammatory response in oleic acid-induced lung injury and whole-lung lavage-induced lung injury. J Anesth2007; 21: 47–54.
35.
VincentJLZambonM: Why do patients who have acute lung injury/acute respiratory distress syndrome die from multiple organ dysfunction syndrome? Implications for management. Clin Chest Med2006; 27: 725–731.
ShafferTHWolfsonMRGreenspanJS: Liquid ventilation in premature lambs: uptake, biodistribution and elimination of perfluorodecalin liquid. Reprod Fertil Dev1996; 8: 409–416.
38.
GregorTSchmalischGBurkhardtW: Aerosolization of perfluorocarbons during mechanical ventilation: an in vitro study. Intensive Care Med2003; 29: 1354–1360.
39.
D'OrthoMPJarreauPHDelacourtC: Matrix metalloproteinase and elastase activities in LPS-induced acute lung injury in guinea pigs. Am J Physiol1994; 266: L209–L216.
40.
OhnoIOhtaniHNittaY: Eosinophils as a source of matrix metalloproteinase-9 in asthmatic airway inflammation. Am J Respir Cell Mol Biol1997; 16: 212–219.
41.
TrocméCGaudinPBerthierS: Human B lymphocytes synthesize the 92-kDa gelatinase, matrix metalloproteinase-9. J Biol Chem1998; 273: 20677–20684.
42.
PartridgeCAJeffreyJJMalikAB: A 96-kDa gelatinase induced by TNF-alpha contributes to increased microvascular endothelial permeability. Am J Physiol1993; 265: L438–L447.
43.
BuissonACZahmJMPoletteM: Gelatinase B is involved in the in vitro wound repair of human respiratory epithelium. J Cell Physiol1996; 166: 413–426.
44.
SmithTMSteinhornDMThusuK: A liquid perfluorochemical decreases the in vitro production of reactive oxygen species by alveolar macrophages. Crit Care Med1995; 23: 1533–1539.
45.
FernandezRSarmaVYounkinE: Exposure to perflubron is associated with decreased Syk phosphorylation in human neutrophils. J Appl Physiol2001; 91: 1941–1947.
